Sign in

CIK 0001743881

  • Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,117,307
in 3 filings, $5.1M under 10b5-1 plans

Net −$5,117,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-06-03 Stolz Brian M. Chief Operating Officer Grant or award · Restricted Stock Units +25,532 25,532
2020-06-03 Kumar Neil CEO and President Sale −5,930 $30.05 $178K 2,319,442
2020-06-03 Kumar Neil CEO and President Grant or award · Stock Option (Right to Buy) +590,551 590,551
2020-06-03 Kumar Neil CEO and President Grant or award · Restricted Stock Units +82,069 82,069
2020-06-02 Cook Jennifer E. Director Grant or award · Stock Option (right to buy) +112,422 112,422
2020-06-02 HOMCY CHARLES J Chairman of Pharmaceuticals Grant or award · Stock Option (right to buy) +112,422 112,422
2020-06-02 MOMTAZEE JAMES C Director Grant or award · Stock Option (right to buy) +112,422 112,422
2020-06-02 Satvat Ali J. Director Grant or award · Stock Option (right to buy) +112,422 112,422
2020-06-02 SCHELLER RICHARD H Director Grant or award · Stock Option (right to buy) +112,422 112,422
2020-06-02 AGUIAR ERIC Director Grant or award · Stock Option (right to buy) +112,422 112,422
2020-06-01 Sinha Uma Chief Scientific Officer Grant or award · Restricted Stock Units +7,500 7,500
2020-06-01 Kumar Neil CEO and President Sale −71,291 $29.13 $2.1M 2,334,081
2020-06-01 Kumar Neil CEO and President Sale −8,709 $29.71 $259K 2,325,372
2020-06-01 STEPHENSON BRIAN C Sale −6,300 $29.31 $185K 309,616
2020-06-01 STEPHENSON BRIAN C Sale −900 $29.74 $27K 308,716
2020-06-01 HENDERSON MICHAEL THOMAS Chief Business Officer Sale −2,085 $29.26 $61K 262,183
2020-06-01 HENDERSON MICHAEL THOMAS Chief Business Officer Sale −500 $29.79 $15K 261,683
2020-05-28 KKR Genetic Disorder L.P. 10% owner Sale −2,389,690 $33.39 $79.8M 34,510,971
2020-05-26 HENDERSON MICHAEL THOMAS Chief Business Officer Exercise or conversion +18,365 $1.05 $19K 264,268
2020-05-26 HENDERSON MICHAEL THOMAS Chief Business Officer Exercise or conversion · Stock Option (Right to Buy) −18,365 0

Page 50 of 61 · 1,201 trades